| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Feb 10, 2025 | 1 | -$58.6K | 4 | Feb 12, 2025 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Feb 5, 2025 | 3 | $1.62M | 4 | Feb 7, 2025 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Jun 14, 2024 | 1 | $25K | 4 | Jun 17, 2024 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Feb 7, 2024 | 5 | $1.6M | 4 | Feb 9, 2024 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Jun 13, 2023 | 1 | -$12.9K | 4 | Jun 14, 2023 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Feb 2, 2023 | 1 | $3.14M | 4 | Feb 3, 2023 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Jun 13, 2022 | 2 | $3.59M | 4 | Jun 15, 2022 | Chief Financial Officer |
| SNDX | Syndax Pharmaceuticals Inc | Jun 13, 2022 | 0 | $0 | 3 | Jun 15, 2022 | Chief Financial Officer |
| OPTN | OptiNose, Inc. | Mar 16, 2022 | 1 | -$9.74K | 4 | Mar 17, 2022 | Chief Financial Officer |
| OPTN | OptiNose, Inc. | Jan 11, 2022 | 3 | $0 | 4 | Jan 12, 2022 | Chief Financial Officer |
| OPTN | OptiNose, Inc. | Dec 16, 2021 | 1 | -$951 | 4 | Dec 17, 2021 | Chief Financial Officer |
| OPTN | OptiNose, Inc. | Sep 16, 2021 | 1 | -$1.61K | 4 | Sep 17, 2021 | Chief Financial Officer |
| OPTN | OptiNose, Inc. | Jun 17, 2021 | 1 | -$2.15K | 4 | Jun 17, 2021 | Chief Financial Officer |